Healthcare & Life Sciences
Ochre Bio
United Kingdomochre-bio.com
Ochre Bio is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 4 tracked investors.
activeseries-b
series-b
Stage
2018
Founded
4
Investors
About Ochre Bio
Ochre Bio is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Ochre Bio is a biotechnology company focused on developing RNA therapies for chronic liver diseases. The company uses a combination of genomic deep phenotyping, precision RNA medicine, and testing to address liver health challenges, with a goal of reducing the need for liver transplants.
Explore Ochre Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.